Among the amplification driver genes, NRAS (in breast carcinoma and skin melanoma), ERBB2 (in gastric carcinoma, esophageal carcinoma), and NFATC2 (in ovarian carcinoma and pancreatic carcinoma) were identified in more than one cancer type. This evidence concerns the gene NFATC2 and gastric carcinoma.